Hepatitis Now: Current Controversies and New Developments in Viral Hepatitis Management

Download slides and audio featuring expert insights on key clinical strategies to meet the most pressing challenges in the management of HCV and HBV.
Robert S. Brown, Jr., MD, MPH

Optimal HBV Treatment Duration

In this downloadable slideset, review metrics that determine when to initiate therapy for chronic hepatitis B, criteria for optimal drug selection, and guidance on treatment withdrawal.

Robert S. Brown, Jr., MD, MPH Released: May 28, 2019

Listen to this on-demand audio for expert perspective on when to consider starting or stopping therapy and what agents to use in patients with chronic hepatitis B.

Robert S. Brown, Jr., MD, MPH Released: August 14, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AbbVie
Gilead Sciences

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?